INTRODUCTION
The matrix metalloproteinases, which include the collagenases, gelatinases and stromelysins, are believed to be important mediators of cartilage destruction occurring in joint pathology. Elevated levels ofcollagenase and stromelysin have been observed in human and canine experimental OA cartilage (Pelletier et al., 1983; Martel-Pelletier et al., 1984; Pelletier and Martel-Pelletier, 1985; Dean et al., 1987; Okada et al., 1992) , and the levels of stromelysin and collagenase found in synovial fluids of patients with rheumatoid arthritis and osteoarthritis are also increased (Walakovits et al., 1992; Lohmander et al., 1993) . The genes for collagenase and stromelysin are induced in vitro in chondrocytes by cytokines such as interleukin-I and tumour necrosis factor ac Hasty et al., 1990b; Richards et al., 1991; Mitchell and Cheung, 1991) . We have shown previously that stromelysin, gelatinases and matrilysin degrade the main cartilage proteoglycan, aggrecan, and we have identified specific cleavage sites within the proteinase-sensitive interglobular domain (Fosang et al., 1991 (Fosang et al., , 1992 . Purified fibroblast collagenase has been shown to degrade cartilage proteoglycan in vitro (Hughes et al., 1991) ; however, the identification of the specific cleavage sites recognized by this enzyme, or by the neutrophil collagenase, has not been described.
Two distinct mammalian collagenase gene products have been identified (Whitham et al., 1986; Wilhelm et al., 1986; Hasty et al., 1990a; Knauper et al., 1990) mains and a C-terminal domain that is thought to confer substrate specificity (Clark and Cawston, 1989; Murphy et al., 1992) . Both collagenases uniquely cleave the three ax chains of types I, II and III collagens at a single locus, producing characteristic TCA and TCB fragments at 25 'C. Different specificities for collagen substrates have been observed (Welgus et al., 198 lb; Hasty et al., 1987; Mallya et al., 1990) and these are thought to be due to differences in the conformational features of the collagen molecules rather than in their primary sequences (Mallya et al., 1990; Netzel-Arnet et al., 1991) . However, little is known about the differences in specificity for substrates other than the collagens .
Collagenase fragments that retain proteolytic activity are derived from autolytic cleavage between the N-and C-terminal portions of the enzymes. This fragmentation occurs naturally in vitro and has been described for both collagenases (BirkedalHansen et al., 1988; Clark and Cawston, 1989; Knauper et al., 1993) . The isolated N-terminal fragment retains its proteolytic activity against casein substrates, but is no longer able to cleave collagen, suggesting that the C-terminal domain is essential for collagen specificity. More recent studies using recombinant collagenase-stromelysin hybrids have shown that both the Nterminal and C-terminal domains contribute towards collagenase specificity .
Aggrecan is the predominant structural proteoglycan present in cartilage, and the accelerated loss of aggrecan in arthritic disease is a major cause of cartilage failure. In this paper we describe the actions of fibroblast and neutrophil collagenases against human and porcine aggrecan and identify specific cleavage sites made by them within the proteinase-sensitive inter- . All other reagents were of analytical grade except for guanidine hydrochloride (Sigma), which was purified with activated charcoal and diatomaceous earth (Sigma). The preparations of aggrecan (Hardingham, 1979; Bayliss and Roughley, 1985) , aggrecan G1-G2 fragments (Fosang and Hardingham, 1989) , specific rabbit antisera against GI and G2 core protein domains (Ratcliffe and Hardingham, 1983; Fosang and Hardingham, 1989) and recombinant human prostromelysin (Docherty and Murphy, 1990; Koklitis et al., 1991) have been described previously.
Preparation and activation of enzymes
Recombinant human fibroblast procollagenase was expressed in NSO cells as described previously . Enzyme activity was approx. 14225 units/mg when determined by the degradation of soluble type I collagen at 25°C and gel scanning (Welgus et al., 1981a) . Human polymorphonuclear (PMN) leucocyte procollagenase was purified to homogeneity as previously described (Knauper et al., 1990) , and identity was confirmed by comparison of the N-terminal sequence of the proenzyme with the sequence of the cDNA clone (Hasty et al., 1990a) . The enzyme had a specific activity of 29096 units/mg, as determined by gel scanning. Purified fibroblast collagenase catalytic fragment (lacking the C-terminal domain) was kindly provided by Dr. I. Clark and Dr. T. Cawston (Clark and Cawston, 1989) , and contained 200 units/mg caseinase activity. Purified PMN leucocyte collagenase catalytic fragment (40 kDa) was prepared by dialysing affinity-purified active PMN leucocyte collagenase (60-100 /ug/ml) against 20 mM Tris/HCl, pH 7.5, 10 mM CaCl2 and 0.5 M NaCl prior to incubation for 24 h at 37°C to allow fragmentation. The fragments were separated using a hydroxamic acid Sepharose column (1.8 cm x 18 cm) (Moore and Spilburg, 1986) . Recombinant PMN collagenase catalytic domain fragment was purified using the same protocol.
substrates. Samples for sequencing were digested with enzymes that had been activated with 1 mM HgCl2 for 1 h at 37°C (Blaser et al., 1991) , and gave identical fragmentation patterns on SDS gels. Enzyme digestions were carried out in buffer containing 10 mM CaCl2, 100 mM NaCl and 50 mM Tris/HCl, pH 7.5, at 37°C and the digests were stopped by the addition of EDTA and 1 ,10-phenanthroline to 10 mM and 2 mM final concentrations respectively. 125I-labelled G1-G2 digestion products were analysed on 5% SDS gels (Fairbanks et al., 1971) . Aggrecan digestion products were analysed on polyacrylamide/agarose composite gels (Carney et al., 1986 ).
Purmcation of coliagenase-derived G2 products and N-terminal sequencing G2 fragments derived from collagenase digests were isolated by size exclusion chromatography on a Bio-Sil SEC 400 h.p.l.c. column after mixing overnight at 4°C with hyaluronan, in order to bind all GI fragments and exclude them in the void of the column (Fosang and Hardingham, 1989; Fosang et al., 1992) . Column fractions were analysed by electrophoresis on 5 % SDS gels (Fairbanks et al., 1971) , and the fractions containing highor low-molecular-mass G2 fragments were pooled separately, dialysed and freeze-dried for N-terminal sequencing as described previously (Sandy et al., 1990) .
RESULTS AND DISCUSSION Coliagenase digestion of aggrecan
Human articular and pig laryngeal aggrecan were digested with fibroblast and neutrophil collagenases and analysed by dissociative composite gel electrophoresis. Samples of undigested human aggrecan contained three distinct bands (Figure 1, lane 1) , while digested fragments migrated on gels with faster relative electrophoretic mobilities (Figure 1, lanes 2-5) . Undigested pig aggrecan migrated as a single species (Figure 1 , lane 6), and had a slower relative mobility than human aggrecan. Both collagenases were able to degrade pig aggrecan into fastermigrating products (Figure 1, lanes 7-10) . Based on the results of digestions at two different enzyme concentrations and the relative mobilities of the digestion products, it appears that the specific activities of both collagenases for aggrecan are similar.
Coliagenase digestion of aggrecan G14G2
An aggrecan G1-G2 fragment has been used to investigate cleavage occurring between the GI and G2 globular protein 
Enzyme digestions
The proenzymes (10 jug) were activated by incubation with 0. Figure 2 Digestion of aI2-labelled aggrecan G1-G2
Purified 1251-labelled G1-G2 was analysed by SDS/PAGE and autoradiography before (lane 1) or after digestion with either fibroblast collagenase (10 jug/ml and 40 ,ug/ml, lanes 2 and 3 respectively) or neutrophil collagenase (10 ,ug/ml and 40 ,ug/ml, lanes 4 and 5 respectively). Samples were digested for 18 h at 37 OC in a total volume of 20 ,ul. The small differences in signal intensity in lanes 2 and 3 are probably due to lower loading.
domains (Fosang et al., 1991) . When digested with fibroblast or neutrophil collagenase, 1251-labelled G1-G2 (150 kDa) gave products of 56 kDa and 110 kDa (Figure 2 ). These were of a similar size to those produced by other metalloproteinases (Fosang et al., 1991 (Fosang et al., , 1992 . However, results from immunolocalization studies with specific anti-GI and anti-G2 antisera showed that although the GI domain was located only in the 56 kDa band, the G2 domain was present in both the 110 kDa and 56 kDa products. This is compatible with two cleavage sites, as was previously found with the low-molecular-mass metalloproteinase matrilysin (Fosang et al., 1992) , but different from the stromelysins and gelatinases that cleave at only a single site. The low-(56 kDa) and high-(l10 kDa) molecular-mass products containing the G2 domain were resolved from each other by sizeexclusion chromatography, and at the same time separated from Gl domain fragments containing GI which were bound to added hyaluronan and eluted in the void volume of the column. N-terminal sequencing of the G2-containing fragments showed the 110 kDa product to be cleaved at Asn341-Phe342 and the 56 kDa product to be cleaved at Asp441-Leu442 (Figure 3) . The products were thus identical to those previously identified in matrilysin digests and, as with matrilysin, the results with collagenase show that cleavage at the Asn341-Phe342 site is more complete than at the Asp441-Leu442 site, otherwise no 110 kDa product containing G2 would be produced. Cleavage at Asn341-Phe342 therefore appears to be more favoured than that at Asp441-Leu442.
Collagenase catalytic fragments lacking the C-terminal hemopexin-like domain were tested for their actions against aggrecan G1-G2. These truncated enzymes are more similar to matrilysin, which also lacks the C-terminal domain. This domain is thought to be involved in the binding of metalloproteinases to triple-helical collagen (Allan et al., 1991; Murphy et al., 1992) , and while it is essential for the specificity of collagenases for collagen (Birkedal-Hansen et al., 1988; Clark and Cawston, 1989; Schnierer et al., 1993) , it does not appear to be essential for the specificity of collagenases for non-collagen substrates , or for stromelysin activity (Okada et al., 1986; Koklitis et al., 1991) . Thus collagenase catalytic fragments were used to determine whether the C-terminal domain has any influence on the specificity of the collagenases for aggrecan. The results showed that, compared with the full-length enzymes, identical digestion products were produced following incubation with either a purified fibroblast collagenase catalytic fragment, or native and recombinant neutrophil collagenase catalytic fragments (Table 1) . Loss of the C-terminal domain of the collagenases did not, therefore, have a role in determining the specificity of the enzymes for either of the two cleavage sites in the aggrecan interglobular domain.
Together with our previous findings, the present results show that all of the known mammalian matrix metalloproteinases cleave aggrecan at a predominant site between Asn341 and Phe342 (human and rat sequences). In addition, fibroblast and neutrophil collagenases, and matrilysin, make a second cleavage in the interglobular domain near to G2, liberating a fragment ofapprox. 100 amino acids that is substituted with several keratan sulphate 
